Return to search

DNA Script inks $200m Series C

DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing.

DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing. The backers included T. Rowe Price Associates and Baillie Gifford.

Source: Press Release